Wells Fargo & Company Kodiak Sciences Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 18,060 shares of KOD stock, worth $51,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,060

Previous 9,990 80.78%

Holding current value

$51,832

Previous $30,000 213.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.01 - $7.45 $24,290 - $60,121	8,070 Added 80.78%	18,060 $94,000
Q4 2023 Feb 09, 2024	BUY	$1.4 - $3.24 $2,762 - $6,392	1,973 Added 24.61%	9,990 $30,000
Q3 2023 Nov 13, 2023	SELL	$1.8 - $7.49 $22,206 - $92,404	-12,337 Reduced 60.61%	8,017 $14,000
Q2 2023 Aug 15, 2023	BUY	$4.3 - $9.48 $62,074 - $136,853	14,436 Added 243.93%	20,354 $140,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $28,465 - $52,551	5,918 New	5,918 $36,000

Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $2,657 - $4,387	-351 Reduced 82.2%	76 $1,000
Q2 2022 Aug 12, 2022	SELL	$5.04 - $9.48 $14,348 - $26,989	-2,847 Reduced 86.96%	427 $3,000
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $152,236 - $1.92 Million	-21,472 Reduced 86.77%	3,274 $25,000
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $138,738 - $220,488	-1,716 Reduced 6.48%	24,746 $2.1 Million
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $850,192 - $1.11 Million	10,372 Added 64.46%	26,462 $2.54 Million
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $780,337 - $1.28 Million	-10,108 Reduced 38.58%	16,090 $1.5 Million
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $1.24 Million - $1.84 Million	-11,196 Reduced 29.94%	26,198 $2.97 Million
Q4 2020 Feb 09, 2021	BUY	$60.78 - $154.03 $1.13 Million - $2.85 Million	18,515 Added 98.07%	37,394 $5.49 Million
Q3 2020 Nov 05, 2020	SELL	$45.05 - $59.27 $505,325 - $664,831	-11,217 Reduced 37.27%	18,879 $1.12 Million
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $135,443 - $209,946	3,169 Added 11.77%	30,096 $1.63 Million
Q1 2020 May 14, 2020	BUY	$38.18 - $73.95 $1.03 Million - $1.99 Million	26,927 New	26,927 $1.28 Million

Others Institutions Holding KOD

# of Institutions

110

Shares Held

43M

Call Options Held

87.8K

Put Options Held

7.3K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $149M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Kodiak Sciences Inc. Transaction History